Lurasidone Linked to Relatively Low Risk for Metabolic Syndrome in Bipolar Depression
Investigators analyzed the potential metabolic effects of lurasidone in a sample of patients with bipolar I depression.
Psych Congress 2019
Complete Coverage
Comorbidity Burden May Increase After Binge Eating Disorder Diagnosis
Patients may be at risk for increased comorbidity burden after a diagnosis of binge eating disorder.
Buprenorphine for Substance Use Disorder: Is Certification Right for Your Practice?
There is enormous need for well-trained providers who are educated in treating opioid use disorder.
Understanding CBD: How to Advise Patients About Existing Laws, Clinical Evidence, and More
At Psych Congress 2018, Andrew Penn from the UCSF School of Nursing provides insight into the use of CBD in clinical practice.
Psychedelic-Assisted Therapy: How MDMA Is Changing Treatment for PTSD
MDMA-assisted psychotherapy has demonstrated early success in PTSD in multiple phase 2 trials.
Novel Trace Amine Receptor Associated With Significant Antipsychotic Effects in Schizophrenia
Researchers evaluated the efficacy and safety of trace amine associated receptor-1 agonist SEP-363856 in patients with schizophrenia.
Transdermal Asenapine: A Promising Potential Treatment Option for Adults With Schizophrenia
If approved, HP-3070 would be the first transdermal antipsychotic available in the United States, and would provide a novel, safe, and efficacious treatment delivery system for adult patients with schizophrenia.
Lofexidine May Effectively Mitigate Symptoms of Opioid Withdrawal Syndrome
Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.
ALKS 3831 May Provide Long-Term Benefits for Acute Schizophrenia
Over the course of 52 weeks, a combination of olanzapine and samidorphan was associated with minimal weight gain, tolerable adverse events, and durable antipsychotic effects in patients with schizophrenia.
Growing Number of PAs Seeing, Treating Mental Health Disorders
Researchers sought to document and describe the contributions of certified PAs across practice areas in addressing mental health conditions.
Dasotraline Improves Body Weight, Compulsive Behaviors in Binge Eating Disorder
Dasotraline may reduce compulsions and obsessive thoughts in adults with binge eating disorder.
Discontinuing Esketamine Nasal Spray Not Linked to Withdrawal Syndrome in Treatment-Resistant Depression
Discontinuing short- or long-term use of esketamine nasal spray for treatment-resistant depression may not be associated with withdrawal symptoms.
Delayed-Release, Extended-Release Methylphenidate Improves Functional Impairment in Pediatric ADHD
In addition to improved symptoms, a delayed-release/extended-release methylphenidate was linked with improvements in early morning and late afternoon/evening functional impairment experienced by children with ADHD.
Relapse More Likely With Antipsychotic Switch in Schizophrenia, Bipolar Disorder, or MDD
Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.
New Medication Combination Promising for Adolescent Borderline Personality Disorder
Off-label use of oxcarbazepine and amantadine HCl appeared effective in maintaining improved symptomology in adolescent female patients with borderline personality disorder.
Want to read more?
Please login or register first to view this content.
Next post in US Psych Congress 2019
